New generation of oral mucosal vaccines targeting dendritic cells

Current Opinion in Chemical Biology

Volumn 17, Issue 6, 2013, Pages 918-924

  Owen, Jennifer L ^a,b   Sahay, Bikash ^a,b   Mohamadzadeh, Mansour ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRITIC CELL VACCINE;

DRUG TARGETING; HUMAN; IMMUNE RESPONSE; LACTIC ACID BACTERIUM; MUCOSAL IMMUNITY; NONHUMAN; REVIEW; VACCINATION;

BACILLUS ANTHRACIS;

ANIMALS; ANTHRAX; BACILLUS ANTHRACIS; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; DENDRITIC CELLS; GENETIC ENGINEERING; HUMANS; IMMUNITY, MUCOSAL; LACTOBACILLUS; PEPTIDES; VACCINATION; VACCINES;

EID: 84890187572     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2013.06.013     Document Type: Review

References (34)

1. Barisani-Asenbauer T., Inic-Kanada A., Belij S., et al. The ocular conjunctiva as a mucosal immunization route: a profile of the immune response to the model antigen tetanus toxoid. PLoS ONE 2013, 8:e60682.
2. Gallo R.L., Hooper L.V. Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol 2012, 12:503-516.
3. Xu J., Gordon J.I. Honor thy symbionts. Proc Natl Acad Sci U S A 2003, 100:10452-10459.
4. Sommer F., Backhed F. The gut microbiota - masters of host development and physiology. Nat Rev Microbiol 2013, 11:227-238.
5. Dongarra M.L., Rizzello V., Muccio L., et al. Mucosal immunology and probiotics. Curr Allergy Asthma Rep 2013, 13:19-26.
6. Rhee J.H., Lee S.E., Kim S.Y. Mucosal vaccine adjuvants update. Clin Exp Vaccine Res 2012, 1:50-63.
7. Pulendran B., Ahmed R. Immunological mechanisms of vaccination. Nat Immunol 2011, 12:509-517.
8. Lycke N. Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol 2012, 12:592-605.
9. Chen K., Cerutti A. Vaccination strategies to promote mucosal antibody responses. Immunity 2010, 33:479-491.
10. Woodrow K.A., Bennett K.M., Lo D.D. Mucosal vaccine design and delivery. Annu Rev Biomed Eng 2012, 14:17-46.
11. Sutherland D.B., Fagarasan S. IgA synthesis: a form of functional immune adaptation extending beyond gut. Curr Opin Immunol 2012, 24:261-268.
12. Rescigno M. Dendritic cells in oral tolerance in the gut. Cell Microbiol 2011, 13:1312-1318.
13. Merad M., Sathe P., Helft J., et al. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 2013, 31:563-604.
14. Varol C., Vallon-Eberhard A., Elinav E., et al. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 2009, 31:502-512.
15. Rescigno M. Dendritic cells in bacteria handling in the gut. J Leukoc Biol 2011, 90:669-672.
16. Farache J., Zigmond E., Shakhar G., Jung S. Contributions of dendritic cells and macrophages to intestinal homeostasis and immune defense. Immunol Cell Biol 2013, 91:232-239.
17. Chinen T., Rudensky A.Y. The effects of commensal microbiota on immune cell subsets and inflammatory responses. Immunol Rev 2012, 245:45-55.
18. Fujkuyama Y., Tokuhara D., Kataoka K., et al. Novel vaccine development strategies for inducing mucosal immunity. Expert Rev Vaccines 2012, 11:367-379.
19. Duluc D., Gannevat J., Anguiano E., et al. Functional diversity of human vaginal APC subsets in directing T-cell responses. Mucosal Immunol 2013, 6:626-638.
20. Rappuoli R., Mandl C.W., Black S., De Gregorio E. Vaccines for the twenty-first century society. Nat Rev Immunol 2011, 11:865-872.
21. Leblanc J.G., Aubry C., Cortes-Perez N.G., et al. Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update. FEMS Microbiol Lett 2013.
22. Wells J. Mucosal vaccination and therapy with genetically modified lactic acid bacteria. Annu Rev Food Sci Technol 2011, 2:423-445.
23. van Baarlen P., Wells J.M., Kleerebezem M. Regulation of intestinal homeostasis and immunity with probiotic lactobacilli. Trends Immunol 2013, 34:208-215.
24. Mohamadzadeh M., Duong T., Hoover T., Klaenhammer T.R. Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria. Expert Rev Vaccines 2008, 7:163-174.
25. Mohamadzadeh M., Klaenhammer T.R. Specific Lactobacillus species differentially activate Toll-like receptors and downstream signals in dendritic cells. Expert Rev Vaccines 2008, 7:1155-1164.
26. Mohamadzadeh M., Olson S., Kalina W.V., et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci U S A 2005, 102:2880-2885.
27. Waithman J., Mintern J.D. Dendritic cells and influenza A virus infection. Virulence 2012, 3.
28. Curiel T.J., Morris C., Brumlik M., et al. Peptides identified through phage display direct immunogenic antigen to dendritic cells. J Immunol 2004, 172:7425-7431.
29. Erskine C.L., Krco C.J., Hedin K.E., et al. MHC class II epitope nesting modulates dendritic cell function and improves generation of antigen-specific CD4 helper T cells. J Immunol 2011, 187:316-324.
30. Chitlaru T., Altboum Z., Reuveny S., Shafferman A. Progress and novel strategies in vaccine development and treatment of anthrax. Immunol Rev 2011, 239:221-236.
31. Mohamadzadeh M., Durmaz E., Zadeh M., et al. Targeted expression of anthrax protective antigen by Lactobacillus gasseri as an anthrax vaccine. Future Microbiol 2010, 5:1289-1296.
32. Mohamadzadeh M., Duong T., Sandwick S.J., et al. Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge. Proc Natl Acad Sci U S A 2009, 106:4331-4336.
33. Kathania M., Zadeh M., Lightfoot Y.L., et al. Colonic immune stimulation by targeted oral vaccine. PLoS ONE 2013, 8:e55143.
34. Douglas G.L., Klaenhammer T.R. Directed chromosomal integration and expression of the reporter gene gusA3 in Lactobacillus acidophilus NCFM. Appl Environ Microbiol 2011, 77:7365-7371.